How pain management groups structure vendor review
With both interventional pain and rehabilitation specialties represented in Charleston's provider base, vendor evaluation in this specialty often runs through more than one clinical reviewer before a purchasing decision is made. The review typically focuses on sourcing, processing description and independent testing results rather than marketing claims.
Precision Biologics supplies certificates of analysis, donor eligibility summaries and, for exosome products, supplier characterization data including particle analysis methods, to verified accounts for this purpose.
- Lot-specific certificate of analysis
- Donor eligibility and screening summary
- Supplier characterization data for exosome products
- Third-party sterility testing results
Charleston
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
82- Pain Medicine
- 35
- Physical Medicine & Rehabilitation
- 47
Receiving cryopreserved and shelf-stable shipments
Cryopreserved formats arrive overnight on dry ice and require -80 degree Celsius storage immediately on receipt. Lyophilized formats are described by the supplier as shelf-stable under normal storage and do not need cryogenic equipment. A practice ordering across both categories should set up two separate receiving workflows rather than one.
Opening an NPI-verified account
Accounts require a National Provider Identifier, and orders are limited to licensed professionals. Multi-provider pain management groups commonly designate a single office administrator to hold the verified account and route approvals to individual physicians internally.
Confirming regulatory status before purchasing
Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, and FDA has stated no exosome product is currently FDA-approved. For Wharton's jelly products, whether a specific intended use fits the applicable HCT/P framework is a determination for the practice and its own counsel. South Carolina pain management groups should confirm current requirements with the South Carolina Board of Medical Examiners and legal counsel.
These products are not FDA approved or licensed for any disease or condition.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Do pain management and rehabilitation practices need separate accounts if they share a billing entity?+
Each verified account is tied to a National Provider Identifier, so practices sharing a billing entity but holding distinct NPIs can set up separate accounts if needed.
Is there a minimum order size for cryopreserved products?+
Pricing and order details are available to verified accounts; we don't publish order minimums publicly. Contact us after account verification for specifics.
Can we get the characterization data for exosome products before deciding?+
Yes. Supplier-reported characterization data, including particle analysis methods and marker testing, is available to verified accounts on request.